Correction to: Underexpression of Carbamoyl Phosphate Synthetase I as Independent Unfavorable Prognostic Factor in Intrahepatic Cholangiocarcinoma: A Potential Theranostic Biomarker (Diagnostics, (2023), 13, 13, (2296), 10.3390/diagnostics13132296)

In the original publication [1], there was a mistake in Figure 3B as published. The group with the poorer outcome in Figure 3B should have been labeled “CPS1 Low Exp”. The corrected Figure 3 appears below. There was an error in the original publication. “Disease-free survival (DFS)” should be replaced with “disease-specific survival (DSS)”. A correction has also been made to the Abstract: CPS1 underexpression was not only negatively correlated to overall survival (OS), disease-specific survival (DSS), local recurrence-free survival (LRFS) and metastasis-free survival (MeFS) in univariate analysis but also an independent prognosticator to forecast poorer clinical outcome for all prognostic indices (OS, DSS, LRFS and MeFs) in patients with IHCC (all p ≤ 0.001). A correction has also been made to the Discussion section, Paragraph 4: Furthermore, CPS1 underexpression was not only negatively correlated to overall survival (OS), disease-specific survival (DSS), local recurrence-free survival (LRFS) and metastasis-free survival (MeFS) in univariate analysis but also an independent prognosticator to forecast poorer clinical outcome for all prognostic indices (OS, DSS, LRFS and MeFs) in patients with IHCC (all p ≤ 0.001). The authors state that the scientific conclusions are unaffected. This correction was approved by the Academic Editor. The original publication has also been updated.